BIM
IPXL

Bogle Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Bogle Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-612,236
Closed -$12.4M – 402
2017
Q3 		$12.4M Buy
+612,236
New +$11.7M 0.85% 40
2017
Q1 		– Sell
-224,721
Closed -$2.98M – 432
2016
Q4 		$2.98M Buy
+224,721
New +$3.84M 0.21% 145
2014
Q3 		– Sell
-32,616
Closed -$978K – 435
2014
Q2 		$978K Buy
32,616
+2,800
+9% +$75.5K 0.07% 237
2014
Q1 		$787K Sell
29,816
-207,810
-87% -$5.19M 0.05% 285
2013
Q4 		$5.97M Buy
237,626
+67,945
+40% +$1.52M 0.5% 81
2013
Q3 		$3.47M Buy
+169,681
New +$3.5M 0.35% 108

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bogle Investment Management's IPXL Position: Q4 2017 in Review

Bogle Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 612,236 shares — an estimated $12.4M sold.

Bogle Investment Management first reported a position in IPXL in Q3 2013 and held it in 6 quarters. The position peaked at $12.4M in Q3 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Bogle Investment Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bogle Investment Management sold 612,236 Impax Laboratories, Inc. shares in Q4 2017, an estimated $12.4M.
  • Bogle Investment Management first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 6 quarters.
  • Bogle Investment Management's Impax Laboratories, Inc. position peaked at $12.4M in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Bogle Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.